Serum levels of CXCL10 and CXCL13 in RA patients are significantly higher than in healthy controls [34], and future studies will be needed to assess whether chemokine levels in the subsets of RA patients based on the clinical response to TNF inhibitor therapy are higher than the normal range. Here, CXCL13 is linked to rheumatoid arthritis.